Table 3.
EBUS-GS group | EBUS-TBNA group | |
---|---|---|
Stage (n) | n (%a) | n (%a) |
NSCLC | ||
I (55) | 9 (16.4) | 6 (10.9) |
II (23) | 4 (17.4) | 2 (8.7) |
III (75) | 9 (12.0) | 23 (30.7) |
IV (135) | 12 (8.9) | 21 (15.6) |
SCLC | ||
Limited (18) | 0 (0) | 8 (44.4) |
Extensive (20) | 0 (0) | 2 (10.0) |
Overall (326) | 34 (10.4)b | 62 (19.0)b |
aPercentage within cancer stage
bIncludes 6 patients who had both EBUS-GS and EBUS-TBNA